Wells Fargo Maintains Equal-Weight on Bristol-Myers Squibb, Raises Price Target to $65

Wells Fargo analyst Mohit Bansal maintains Bristol-Myers Squibb (NYSE:BMY) with a Equal-Weight and raises the price target from $60 to $65.